医学：利用RNA使病毒沉默 - Suppr

Suppr

超能文献

Medicine: silencing viruses with RNA.

作者信息

Carmichael Gordon G

出版信息

Nature. 2002 Jul 25;418(6896):379-80. doi: 10.1038/418379a.

DOI:10.1038/418379a

PMID:12140542

Abstract

摘要

相似文献

Medicine: silencing viruses with RNA.

Nature. 2002 Jul 25;418(6896):379-80. doi: 10.1038/418379a.

Short interfering RNA confers intracellular antiviral immunity in human cells.

Nature. 2002 Jul 25;418(6896):430-4. doi: 10.1038/nature00873. Epub 2002 Jun 26.

Choosing CCR5 or Rev siRNA in HIV-1.

Nat Biotechnol. 2003 Mar;21(3):230-1. doi: 10.1038/nbt0303-230.

RNA-dependent RNA polymerases, viruses, and RNA silencing.

Science. 2002 May 17;296(5571):1270-3. doi: 10.1126/science.1069132.

Modulation of HIV-1 replication by RNA interference.

Nature. 2002 Jul 25;418(6896):435-8. doi: 10.1038/nature00896. Epub 2002 Jun 26.

Induction and suppression of RNA silencing by an animal virus.

Science. 2002 May 17;296(5571):1319-21. doi: 10.1126/science.1070948.

Small RNAs: the genome's guiding hand?

Nature. 2002;420(6917):732. doi: 10.1038/420732a.

Ancient pathways programmed by small RNAs.

Science. 2002 May 17;296(5571):1265-9. doi: 10.1126/science.1072457.

RNA silencing: the genome's immune system.

Science. 2002 May 17;296(5571):1263-5. doi: 10.1126/science.1072148.

Molecular biology. RNAi and heterochromatin--a hushed-up affair.

Science. 2002 Sep 13;297(5588):1818-9. doi: 10.1126/science.1075874. Epub 2002 Aug 22.

引用本文的文献

Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation.

Allergy. 2021 Sep;76(9):2840-2854. doi: 10.1111/all.14850. Epub 2021 May 10.

Silencing HCV Replication in Its Reservoir.

Open Access Maced J Med Sci. 2018 Nov 16;6(11):1965-1971. doi: 10.3889/oamjms.2018.372. eCollection 2018 Nov 25.

Trans-splicing group I intron targeting hepatitis C virus IRES mediates cell death upon viral infection in Huh7.5 cells.

Virology. 2015 Jul;481:223-34. doi: 10.1016/j.virol.2015.02.023. Epub 2015 Apr 7.

Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.

Nat Protoc. 2013 Sep;8(9):1635-59. doi: 10.1038/nprot.2013.097. Epub 2013 Aug 1.

Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.

RNA. 2013 Jun;19(6):767-77. doi: 10.1261/rna.037002.112. Epub 2013 Apr 19.

Fluorogenic RNA nanoparticles for monitoring RNA folding and degradation in real time in living cells.

Nucleic Acid Ther. 2012 Dec;22(6):428-37. doi: 10.1089/nat.2012.0380. Epub 2012 Oct 31.

Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology.

Nucleic Acid Ther. 2012 Aug;22(4):226-45. doi: 10.1089/nat.2012.0350.

Assembly of therapeutic pRNA-siRNA nanoparticles using bipartite approach.

Mol Ther. 2011 Jul;19(7):1304-11. doi: 10.1038/mt.2011.23. Epub 2011 Apr 5.

In vitro inhibition of porcine hemagglutinating encephalomyelitis virus replication with siRNAs targeting the spike glycoprotein and replicase polyprotein genes.

Intervirology. 2012;55(1):53-61. doi: 10.1159/000323523. Epub 2011 Mar 3.

Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.

Methods. 2011 Jun;54(2):204-14. doi: 10.1016/j.ymeth.2011.01.008. Epub 2011 Feb 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Medicine: silencing viruses with RNA.

Nature. 2002 Jul 25;418(6896):379-80. doi: 10.1038/418379a.

Short interfering RNA confers intracellular antiviral immunity in human cells.

Nature. 2002 Jul 25;418(6896):430-4. doi: 10.1038/nature00873. Epub 2002 Jun 26.

Choosing CCR5 or Rev siRNA in HIV-1.

Nat Biotechnol. 2003 Mar;21(3):230-1. doi: 10.1038/nbt0303-230.

RNA-dependent RNA polymerases, viruses, and RNA silencing.

Science. 2002 May 17;296(5571):1270-3. doi: 10.1126/science.1069132.

Modulation of HIV-1 replication by RNA interference.

Nature. 2002 Jul 25;418(6896):435-8. doi: 10.1038/nature00896. Epub 2002 Jun 26.

Induction and suppression of RNA silencing by an animal virus.

Science. 2002 May 17;296(5571):1319-21. doi: 10.1126/science.1070948.

Small RNAs: the genome's guiding hand?

Nature. 2002;420(6917):732. doi: 10.1038/420732a.

Ancient pathways programmed by small RNAs.

Science. 2002 May 17;296(5571):1265-9. doi: 10.1126/science.1072457.

RNA silencing: the genome's immune system.

Science. 2002 May 17;296(5571):1263-5. doi: 10.1126/science.1072148.

Molecular biology. RNAi and heterochromatin--a hushed-up affair.

Science. 2002 Sep 13;297(5588):1818-9. doi: 10.1126/science.1075874. Epub 2002 Aug 22.

引用本文的文献

Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation.

Allergy. 2021 Sep;76(9):2840-2854. doi: 10.1111/all.14850. Epub 2021 May 10.

Silencing HCV Replication in Its Reservoir.

Open Access Maced J Med Sci. 2018 Nov 16;6(11):1965-1971. doi: 10.3889/oamjms.2018.372. eCollection 2018 Nov 25.

Trans-splicing group I intron targeting hepatitis C virus IRES mediates cell death upon viral infection in Huh7.5 cells.

Virology. 2015 Jul;481:223-34. doi: 10.1016/j.virol.2015.02.023. Epub 2015 Apr 7.

Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.

Nat Protoc. 2013 Sep;8(9):1635-59. doi: 10.1038/nprot.2013.097. Epub 2013 Aug 1.

Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.

RNA. 2013 Jun;19(6):767-77. doi: 10.1261/rna.037002.112. Epub 2013 Apr 19.

Fluorogenic RNA nanoparticles for monitoring RNA folding and degradation in real time in living cells.

Nucleic Acid Ther. 2012 Dec;22(6):428-37. doi: 10.1089/nat.2012.0380. Epub 2012 Oct 31.

Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology.

Nucleic Acid Ther. 2012 Aug;22(4):226-45. doi: 10.1089/nat.2012.0350.

Assembly of therapeutic pRNA-siRNA nanoparticles using bipartite approach.

Mol Ther. 2011 Jul;19(7):1304-11. doi: 10.1038/mt.2011.23. Epub 2011 Apr 5.

In vitro inhibition of porcine hemagglutinating encephalomyelitis virus replication with siRNAs targeting the spike glycoprotein and replicase polyprotein genes.

Intervirology. 2012;55(1):53-61. doi: 10.1159/000323523. Epub 2011 Mar 3.

Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.

Methods. 2011 Jun;54(2):204-14. doi: 10.1016/j.ymeth.2011.01.008. Epub 2011 Feb 12.